Novozymes confirms 2026 organic sales growth outlook of 7-8%

Bitget2026/11/05 07:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Novozymes confirmed its 2026 organic sales growth outlook of 7-8%.
Adjusted EBITDA margin is expected at the higher end of the 37-38% range.
Fourth-quarter organic sales growth is projected in the high single digits.
Full-year growth excludes an expected drag of close to 1 percentage point from exiting certain countries.
Nine-month organic sales growth reached 7%, with an adjusted EBITDA margin of 37.9%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novozymes A/S published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Novozymes confirms 2026 organic sales growth outlook of 7-8%

You may also like

Crypto prices